Update on targeted biopharmaceuticals in systemic sclerosis!

We present here the results of the trials published in the last 5 years in ScS according to the chosen endpoint criteria and describe the trials in progress or expected in the years to come.PMID:37980267 | DOI:10.1016/j.revmed.2023.11.002

Source: Revue de Medecine Interne - November 18, 2023 Category: Internal Medicine Authors: B Chaigne L Mouthon Source Type: research